The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.43

Today's change+0.11 +0.89%
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.43

Today's change+0.11 +0.89%
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc Hits New 20-day High

Allscripts Healthcare Solutions Inc closed up Thursday by (U.S.)$0.11 or 0.89% to (U.S.)$12.43 and setting a new 20-day high. Over the last five days, shares have gained 6.79%, but are down 19.60% for the last year to date. Shares have underperformed the S&P 500 by 31.25% during the last year.

Key company metrics

  • Open(U.S.) $12.46
  • Previous close(U.S.) $12.32
  • High(U.S.) $12.52
  • Low(U.S.) $12.31
  • Bid / Ask(U.S.) $12.42 / (U.S.) $12.49
  • YTD % change-19.60%
  • Volume1,701,099
  • Average volume (10-day)2,224,375
  • Average volume (1-month)2,226,477
  • Average volume (3-month)2,649,865
  • 52-week range(U.S.) $11.00 to (U.S.) $19.68
  • Beta1.11
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward39.09×
  • Forward PEG1.57×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.47
Updated December 18 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-6.12%

Allscripts Healthcare Solutions Inc has a net profit margin of -6.12%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.93%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue345351340351
Total other revenue--------
Total revenue345351340351
Gross profit131140138138
Total cost of revenue214211202213
Total operating expense364360352379
Selling / general / administrative978790109
Research & development46535248
Depreciation / amortization7888
Interest expense (income), net operating--------
Unusual expense (income)0201
Other operating expenses, total--------
Operating income-19-9-12-28
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-26-16-19-35
Income after tax-26-18-21-21
Income tax, total022-14
Net income-26-18-21-21
Total adjustments to net income--------
Net income before extra. items-26-18-21-21
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-26-18-21-21
Inc. avail. to common incl. extra. items-26-18-21-21
Diluted net income-26-18-21-21
Dilution adjustment--000
Diluted weighted average shares180180179179
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.10-0.12-0.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.14-0.07-0.12-0.11